Anticoagulation challenges in cancer patients: prevention, detection, and treatment strategies
Simona Chiusolo·Daniel Lenihan·Eric Oligino·Avirup Guha·Husam Abdel-Qadir·Joseph Carver·Stephen Casselli·Chelsea Kriesberg
Cancer-associated thrombosis is one of the most common and serious complications in oncology patients, contributing significantly to morbidity and mortality. This prothrombotic state is driven by cancer-related factors, systemic inflammation, and treatment-induced endothelial injury. Anticoagulation management in these patients is challenging, as both thrombotic and bleeding risks must be carefully balanced, particularly in those with cardiovascular comorbidities. This review examines the comple